Evaluation of dalbavancin alone and in combination with &bgr;-lactam antibiotics against resistant phenotypes of Staphylococcus aureus
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dky376
Abstract: Background Emergence of reduced susceptibility to vancomycin warrants the development of new antimicrobial agents for the treatment of MRSA. We evaluated the activity of dalbavancin, a novel lipoglycopeptide antibiotic, both alone and combined with β-lactams,… read more here.
Keywords: combination; phenotypes staphylococcus; resistant phenotypes; dalbavancin ... See more keywords